OMICS Group Declares The Acquisition Of The Journal-Immunome Research

Press Release | OMICS Group | July 25, 2013

HENDERSON, NV, USA, July 25, 2013 / -- OMICS Group Inc., a scientific organization that drives the progress of research through open access journals, announced a landmark agreement with Nikolai Petrovsky Publishing for acquisition of Immunome Research, an Open access, Peer reviewed, interdisciplinary journal, which is also an official journal of the International Immunomics Society (IIMMS).

Immunome research (ISSN: 1745-7580) indexing in PubMed, and many other esteemed indexing services, came to life in 2005 through Biomed Central, bringing the prime focus in the nascent field of immunomics, which includes traditional wet lab immunology research approaches with the new sciences of Genomics, Proteomics, and Bioinformatics as well as mathematical modelling. Later in 2011, it was transferred to an open source journal publishing system, with Nikolai Petrovsky Publishing as its new publisher.

Recently in June 2013, Dr. Srinubabu Gedela, CEO, OMICS Group Inc. signed an agreement with Dr. Nikolai Petrovsky, Proprietor, Nikolai Petrovsky Publishing for acquiring Immunome Research journal.

Dr. Srinubabu Gedela says, "This acquisition will ensure that the journal continues to promote the findings of contemporary research in the exciting and challenging field of Immunomics." We will do our best to reshape IMR into a high-quality top journal. In order to meet the goal, we have created the Advisory Editorial Board, consisting of world-class, excellent and experienced professors and researchers in the field of immunomics. We have also implemented a very efficient Editorial managing system for streamlining the whole process from manuscript submission to online publication for authors.”

More about OMICS Group:
Dr. Srinubabu Gedela founded OMICS Group Incorporation in 2007, with a mission of making the scientific information Open Access. OMICS Group hosts over 300 leading-edge peer reviewed Open Access journals and has organised over 100 scientific conferences all over the world. Success of the same can be attributed to the strong editorial board which contains over 20000 eminent personalities and about 2 million readers. OMICS has started new initiatives: SciTechnol, E-Books, Scholars Central, Clinical and Expert Database, Bio safety Protocols, and E-BABE.

More about Nikolai Petrovsky:
Dr. Nikolai Petrovsky, Proprietor, Nikolai Petrovsky Publishing is a director of endocrinology at flinders medical centre with a conjoint position as professor of medicine at flinders university. He is also vice-president and secretary-general of the international immunomics society. Active in diabetes, endocrinology and vaccine research, he is the founder of vaxine, a company funded by the US National Institutes of Health to develop novel vaccine technologies. In 2009 vaxine won the amp innovation award at the telstra business awards and Australia's coolest company award from Australian anthill magazine. To continue the legacy of the journal Prof. Nikolai agreed to serve as an “Honorary Patron” of the new Immunome Research Journal under OMICS Group.

For more details about the journal and special issue, please visit the URL:

For more details Contact
DR Van
Immunome Research
OMICS Group Incorporation
2360 Corporate Circle
Suite 400, Henderson
NV 89074-7722, USA
Phone: +1- 888-843-8169
Fax: +1-650-618-1417
Toll Free: +1-800-216-6499
Email: [email protected] or [email protected]
DR Van
OMICS Group Incorporation
email us here